Quotes Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Stocks
OJU1
US68403P2039
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:02:26 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 4.280 EUR | -0.81% |
|
+5.42% | +77.45% |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
| 08-10 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Deutsche Boerse AG
OJU1 4.280 €
-0.81%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ORMP | 5.020USD | -0.20% | 1.22M $ | ||
CBOE
| ORMP | 5.030USD | -.--% | 57.14K $ | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,493.00ILa | -0.47% | 8.56M ILa | |
|
Tradegate
| OJU1 | 4.330EUR | -0.35% | 653.83 € | |
|
Deutsche Boerse AG
| OJU1 | 4.280EUR | -0.81% | 0 € | |
|
Börse Stuttgart
| OJU1 | 4.300EUR | +0.23% | 0 € | |
|
Boerse Muenchen
| OJU1 | 4.290EUR | -2.17% | 0 € |
Quotes 5-day view: Oramed Pharmaceuticals Inc.
Delayed Quote Deutsche Boerse AG
| 2026-08-25 | 2026-08-26 | 2026-08-27 | 2026-08-28 | 2026-08-31 | |
|---|---|---|---|---|---|
| Last | €4.070 | €4.420 | €4.530 | €4.315 | €4.280 |
| Change | +0.25% | +8.60% | +2.49% | -4.75% | -0.81% |
Performance
| 1 day | -0.81% | ||
| 1 week | +5.42% | ||
| Current month | +21.25% | ||
| 1 month | +21.25% | ||
| 3 months | +23.52% | ||
| 6 months | +51.24% | ||
| Current year | +77.45% | ||
| 1 year | +132.61% | ||
| 3 years | +42.52% | ||
| 5 years | -74.76% | ||
| 10 years | -33.35% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
180
Daily volume ratio
0
Avg. Volume 20 sessions
770.4
Avg. Volume 20 sessions USD
894.51
Record volume 1
98,495
Record volume 2
60,675
Record volume 3
58,541
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
209,234,690
Market Cap (USD)
209,234,690
Net sales (USD)
2,000,000
Number of employees
4
Sales / Employee (USD)
500,000
Free-Float
82.35 %
Free-Float capitalization (EUR)
200,122,575
Free-Float capitalization (USD)
172,305,537
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
4.279
Moving average 20 days
3.917
Moving average 50 days
3.783
Moving average 100 days
3.582
Price spread / (MMA5)
-0.02%
Price spread / (MMA20)
-8.48%
Price spread / (MMA50)
-11.61%
Price spread / (MMA100)
-16.30%
RSI 9 days
65.36
RSI 14 days
63.71
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | +5.42% | +132.61% | +42.52% | 209M | |
| -1.23% | -1.91% | +0.98% | +17.94% | 50.47B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.56B | |
| -0.21% | +0.37% | +36.88% | +17.32% | 43.08B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 41.7B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.21B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.77B | |
| +6.10% | +4.40% | - | - | 16.28B | |
| +0.25% | -0.98% | +11.91% | +27.62% | 14.58B | |
| -1.12% | -3.46% | +76.50% | +39.37% | 13.92B | |
| Average | -0.21% | -1.79% | +81.23% | +98.87% | 27.48B | |
| Weighted average by Cap. | -0.60% | -1.57% | +88.99% | +122.78% |
Historical Quotes: Oramed Pharmaceuticals Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 4.07 |  | 4.53 |
| 1 month | 3.48 | | 4.53 |
| Current year | 2.4 | | 4.53 |
| 1 year | 1.83 | | 4.53 |
| 3 years | 1.6 | | 4.53 |
| 5 years | 1.6 | | 26.25 |
| 10 years | 1.6 | | 26.25 |
Monthly variations
Annual variations
| 2026 | +77.45% | ||
| 2025 | +6.87% | ||
| 2024 | +7.94% | ||
| 2023 | -81.46% | ||
| 2022 | -.--% | ||
| 2021 | +219.09% | ||
| 2020 | -22.14% | ||
| 2019 | +71.97% | ||
| 2018 | -65.36% | ||
| 2017 | +30.50% | ||
| 2016 | -27.30% | ||
| 2015 | +125.71% | ||
| 2014 | +26.21% | ||
| 2012 | +47.80% | ||
| 2011 | -33.19% | ||
| 2010 | -14.08% | ||
| 2009 | +13.99% | ||
| 2008 | +62.00% | ||
| 2007 | -73.21% | ||
| 2006 | -28.21% |
- Stock Market
- Stocks
- ORMP Stock
- OJU1 Stock
- Quotes Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
